• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25REC W/RES; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25REC W/RES; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3CX*FX25REC
Device Problem Complete Blockage (1094)
Patient Problem No Patient Involvement (2645)
Event Date 10/16/2017
Event Type  malfunction  
Manufacturer Narrative
Terumo has received the device for evaluation; however, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.For this reason, terumo references (b)(4).
 
Event Description
The user facility reported to terumo cardiovascular that during prime, the pigtail of the plegia port was clogged.  *no patient involvement, *product was changed out, *procedure was completed successfully.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations.The returned sample was visually inspected.No damages were present in the affected area of the product.No other visual anomalies were noted.A syringe filled with water was attached to the luer port at the end of the pigtail line, and then an attempt was made to push water through the line.This was unsuccessful confirming the blocked port.Additionally, water was placed into the blood outlet port of the oxygenator and attempted to be pulled through the pigtail line; this was also unsuccessful.A retention sample of the same product code and lot number combination was retrieved.Visual inspection of the retention sample concluded with no noted visual anomalies.The retention sample was tested with positive and negative flow through the pigtail line, and each attempt passed.The cause of the event is excess bonding agent on the tubing when it is inserted into the port, causing the bonding agent to be pushed down the outside of the tubing by the port.The bonding agent then dries on the outside of the tubing allowing it to block the port.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STERILE FX25REC W/RES
Type of Device
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
Manufacturer Contact
cathleen hargreaves
125 blue ball road
elkton, MD 21921
8002837866
MDR Report Key6996424
MDR Text Key91926290
Report Number1124841-2017-00229
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K151791
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/21/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Model Number3CX*FX25REC
Device Catalogue NumberN/A
Device Lot NumberVH24
Other Device ID Number(01)00699753450820
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/24/2017
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 10/17/2017
Initial Date FDA Received11/02/2017
Supplement Dates Manufacturer Received12/20/2017
Supplement Dates FDA Received12/21/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/24/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-